Skip to content
Announcement:

Join us at this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

The aProximate™ in vitro renal proximal tubule cell model as a platform to investigate the renal uptake and nephrotoxic liability of Antisense Oligonucleotide drug molecules

Published

16th June, 2023

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Many biologics accumulate in the kidney and may cause unforeseen kidney injury.

Currently there is no in vitro platform that enables cross-species comparisons of drug transport or nephrotoxicity

Download Now

Get our latest updates straight to your inbox